The leading representative office of defined VC is situated in the Wellesley. The fund was located in North America if to be more exact in United States.
The higher amount of exits for fund were in 2017. The fund is constantly included in 2-6 investment rounds annually. The average startup value when the investment from Ampersand Capital Partners is 100-500 millions dollars. The real fund results show that this VC is 25 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this Ampersand Capital Partners works on 6 percentage points more the average amount of lead investments. The important activity for fund was in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight FirstRain, Endeca, Ensemble Communications. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Life Science, Medical. The fund has exact preference in a number of founders of portfolio startups.
This organization was formed by Richard A. Charpie. We also calculated 11 valuable employees in our database.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Ampersand Capital Partners, startups are often financed by Diamondhead Ventures, Venrock, Star Ventures. The meaningful sponsors for the fund in investment in the same round are Diamondhead Ventures, Venrock, Oak Investment Partners. In the next rounds fund is usually obtained by Oak Investment Partners, Venrock, GGV Capital.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Vernal Biosciences | $20M | 27 Jun 2023 | Burlington, Vermont, United States | ||
AnaBios | $6M | 07 Jun 2022 | San Diego, California, United States | ||
Vernal Biosciences | $21M | 02 Jun 2022 | Burlington, Vermont, United States | ||
Arranta Bio | 08 Mar 2021 | Massachusetts, United States | |||
Canopy Biosciences | 01 Jan 2017 | City of Saint Louis, Missouri, United States | |||
01 Jan 2013 | Worcester, Massachusetts, United States | ||||
RadPharm | $10M | 28 Nov 2007 | Belconnen, Australian Capital Territory, Australia | ||
Cequent Pharmaceuticals | $9M | 18 Jun 2007 | Cambridge, Massachusetts, United States | ||
Assay Designs | $5M | 13 May 2005 | Ann Arbor, Michigan, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Vernal Biosciences | $20M | 27 Jun 2023 | Burlington, Vermont, United States | ||
AnaBios | $6M | 07 Jun 2022 | San Diego, California, United States | ||
Vernal Biosciences | $21M | 02 Jun 2022 | Burlington, Vermont, United States | ||
Arranta Bio | 08 Mar 2021 | Massachusetts, United States | |||
Canopy Biosciences | 01 Jan 2017 | City of Saint Louis, Missouri, United States | |||
01 Jan 2013 | Worcester, Massachusetts, United States | ||||
RadPharm | $10M | 28 Nov 2007 | Belconnen, Australian Capital Territory, Australia | ||
Cequent Pharmaceuticals | $9M | 18 Jun 2007 | Cambridge, Massachusetts, United States | ||
Assay Designs | $5M | 13 May 2005 | Ann Arbor, Michigan, United States |